Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             38 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Age and ligand specificity influence the outcome of pathogen engagement on preleukemic and leukemic B-cell precursor populations Atre, Tanmaya

7 22 p. 7087-7099
artikel
2 Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis Murthy, Hemant S.

7 22 p. 7007-7016
artikel
3 Allogeneic T cells cause acute renal injury after hematopoietic cell transplantation Miyata, Masahiro

7 22 p. 6936-6948
artikel
4 American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing Middeldorp, Saskia

7 22 p. 7101-7138
artikel
5 Clearing and replacing tissue-resident myeloid cells with an anti-CD45 antibody–drug conjugate Gustafsson, Karin

7 22 p. 6964-6973
artikel
6 Clearing the way for new therapies in clonal hematopoiesis Ling, Victoria Y.

7 22 p. 7151-7152
artikel
7 Complementary HLH susceptibility factors converge on CD8 T-cell hyperactivation Landy, Emily

7 22 p. 6949-6963
artikel
8 DeFilipp Z, Kim HT, Yang Z, et al. Clinical response to belumosudil in bronchiolitis obliterans syndrome: a combined analysis from 2 prospective trials. Blood Adv. 2022;6(24):6263-6270.
7 22 p. 7006
artikel
9 De novo hematopoiesis from the fetal lung Yeung, Anthony K.

7 22 p. 6898-6912
artikel
10 DuMontier C, La J, Bihn J, et al. More intensive therapy has a better effect for frail parents with multiple myeloma. Blood Adv. 2023;7(20):6275-6284.
7 22 p. 7100
artikel
11 Early quantification of anti-CD19 CAR T cells by flow cytometry predicts response in R/R DLBCL Blumenberg, Viktoria

7 22 p. 6844-6849
artikel
12 Editorial Board
7 22 p. i
artikel
13 Elevated CDKN1A (P21) mediates β-thalassemia erythroid apoptosis, but its loss does not improve β-thalassemic erythropoiesis Liang, Raymond

7 22 p. 6873-6885
artikel
14 Factors associated with long-term outcomes of CD19 CAR T-cell therapy for relapsed/refractory CLL Liang, Emily C.

7 22 p. 6990-7005
artikel
15 Front Matter
7 22 p. ii
artikel
16 Genome editing of patient-derived iPSCs identifies a deep intronic variant causing aberrant splicing in hemophilia A Hiramoto, Takafumi

7 22 p. 7017-7027
artikel
17 HAPLN1 matrikine: a bone marrow homing factor linked to poor outcomes in patients with MM Chang, Hae Yeun

7 22 p. 6859-6872
artikel
18 Ibrutinib in the treatment of relapsed FL and MZL? Schmitz, Norbert

7 22 p. 7139-7140
artikel
19 Impact of circulating lymphoma cells at diagnosis on outcomes in patients with marginal zone lymphoma: a multicenter cohort study Annunzio, Kaitlin

7 22 p. 6839-6843
artikel
20 Impact of preexisting autoimmune disease on myelodysplastic syndromes outcomes: a population analysis Adrianzen-Herrera, Diego

7 22 p. 6913-6922
artikel
21 Impaired fibrinolysis and increased clot strength are potential risk factors for thrombosis in lymphoma Bønløkke, Søren Thorgaard

7 22 p. 7056-7066
artikel
22 Intensive hydroxyurea dosing in very young children with sickle cell anemia Wang, Winfred C.

7 22 p. 6931-6935
artikel
23 International validation of a health-related quality-of-life questionnaire for Hodgkin lymphoma: the EORTC QLQ-HL27 Oerlemans, Simone

7 22 p. 7045-7055
artikel
24 Intrapatient competition of VEXAS syndrome and CML clones Djerbi, Nadia

7 22 p. 6815-6818
artikel
25 Natural history and variability in albuminuria in pediatric and murine sickle cell anemia Kasztan, Malgorzata

7 22 p. 6850-6858
artikel
26 Phase 3 SELENE study: ibrutinib plus BR/R-CHOP in previously treated patients with follicular or marginal zone lymphoma Nastoupil, Loretta J.

7 22 p. 7141-7150
artikel
27 Progenitor-like cell type of an MLL-EDC4 fusion in acute myeloid leukemia Schuster, Linda C.

7 22 p. 7079-7083
artikel
28 Results of VOICE: a global survey of disease-specific knowledge and perspectives of real-world patients with CLL Tam, Constantine

7 22 p. 6819-6828
artikel
29 Risk factors in underweight older children with sickle cell anemia: a comparison of low- to high-income countries Klein, Lauren Jane

7 22 p. 6923-6930
artikel
30 Risky health behaviors and subsequent late mortality after blood or marrow transplantation: a BMTSS report Balas, Nora

7 22 p. 7028-7044
artikel
31 Safety and efficacy of zanubrutinib in relapsed/refractory marginal zone lymphoma: final analysis of the MAGNOLIA study Opat, Stephen

7 22 p. 6801-6811
artikel
32 Schuelke MR, Bassiri H, Behrens EM, et al. Emapalumab for the treatment of refractory cytokine release syndrome in pediatric patients. Blood Adv. 2023;7(18):5603–5607.
7 22 p. 6829
artikel
33 Tagraxofusp for blastic plasmacytoid dendritic cell neoplasm: a 2-speed cure in the United States and European Union Valentini, Caterina Giovanna

7 22 p. 7084-7086
artikel
34 Telomeric repeat-containing RNA is dysregulated in acute myeloid leukemia Catto, Luiz Fernando B.

7 22 p. 7067-7078
artikel
35 Unfavorable transcriptome profiles and social disadvantage in hematopoietic cell transplantation: a CIBMTR analysis Taylor, Mallory R.

7 22 p. 6830-6838
artikel
36 Vitamin C and D supplementation in acute myeloid leukemia Mouchel, Pierre Luc

7 22 p. 6886-6897
artikel
37 VWF–ADAMTS13 axis dysfunction in children with sickle cell disease treated with hydroxycarbamide vs blood transfusion Fogarty, Helen

7 22 p. 6974-6989
artikel
38 World Coalition on SCD launches, sparking global focus on SCD diagnosis and care Zapfel, Andrew

7 22 p. 6812-6814
artikel
                             38 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland